Genetics | Preconception
The screening test that helps identify whether you are a healthy carrier of serious, untreatable genetic conditions
Genetics | Preconception
The screening test that helps identify whether you are a healthy carrier of serious, untreatable genetic conditions
Genetics | Preconception
The screening test that helps identify whether you are a healthy carrier of serious, untreatable genetic conditions
Requires only a simple blood sample
High sensitivity and specificity
Full gene sequencing
Results in 21 working days, 15 days if pregnant
Book your Next Carrier test in 3 simple steps, or complete the contact form at the bottom of the page to request more information:
2. Provide a blood sample (home collection available!)
Receive your report online
In most cases, couples are unaware that they are healthy carriers of genetic conditions, as they show no symptoms and/or have no known family history.
Next Carrier is a preconception genetic screening test that helps prospective parents determine whether they are healthy carriers of genetic conditions that could be passed on to their child.
The test identifies the most common and serious recessive genetic disorders, either autosomal or X-linked.
Its primary goal is to reduce the risk of a child being born with a genetic condition.
It is important to understand that almost all of us, whether we are aware of it or not, carry genetic mutations. However, whether the mutation remains silent or leads to disease depends on how the altered gene is inherited.
The condition develops if just one altered copy of the gene is inherited from either parent
The condition develops only when both copies of the gene one from each parent are altered
If both parents are healthy carriers of an autosomal recessive genetic condition, there is a 25% chance of having an affected child. If the condition is X-linked, the probability rises to 50% in male offspring.
Around 55% of people are carriers of at least one of the conditions screened by the Next Carrier test, which allows couples to be informed of their reproductive risk at an early stage.
Both partners provide a blood sample
Laboratory analysis is performed
Reproductive risk is calculated
Results available in 15 to 20 working days
The test is performed at the Pavia operational site, which implements a quality management system in accordance with ISO 9001:2015 and SIGUCert standards